Skip to content

Annals of Clinical and Analytical Medicine

E-ISSN: 2667-663X · Monthly · English

Factors affecting treatment outcome of acute promyelocytic leukemia in Egyptian patients

Acute promyelocytic leukemia

Abstract

AimAcute promyelocytic leukemia (APL) is a peculiar subtype of acute myeloid leukemia clinically and morphologically. To date, only a few studies reported the treatment outcome of APL in developing countries. Thus, we investigated the challenges and factors affecting APL treatment in Egypt.Methods This study included 27 APL patients treated at Kasr Al Ainy Center of Clinical Oncology and Nuclear Medicine (NEMROCK) – Cairo University hospital, Egypt from 2010 till 2014.ResultsThe mean age at presentation was 35 years, and intermediate and high-risk Sanz scores constituted 44% and 30% of patients, respectively. Complete remission (CR) was achieved by 17 patients (63%), 1 patient had a refractory disease (3.7%), and the response could not be evaluated in 5 patients. No deaths were encountered before treatment, and early mortality rate was 14.8% (n = 4). All patients in CR received consolidation therapy, and molecular remission was achieved by 14 patients (82.4%). By December 2015, relapse occurred in 5 patients (29.4%). The median disease-free survival (DFS) was 27.1 months, the mean overall survival (OS) was 84.4 months, and the median OS was not reached. Factors affecting survival included: body mass index (DFS: P = .012, OS: P = .009), type of induction regimen (OS: P = .007), treatment interruption (OS: P = .035), number of consolidation cycles (OS: P = .001), duration of maintenance therapy (DFS: P = .018) and response to salvage therapy (OS: P = .046).ConclusionsOur findings elucidate the challenges met by developing countries owing to limited resources and financial constraints.

Keywords

acute myeloid leukemia (AML)acute promyelocytic leukemia (APL)survivalmortality raterelapse

Additional Information

Publisher’s Note
Bayrakol MP remains neutral with regard to jurisdictional and institutional claims.

Rights and Permissions

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/

About This Article

How to Cite This Article

Hamdy M. Zawam, Mohsen M. Mokhtar, Rasha Salama, Samy A. Alsirafy, Mai K. Bishr. Factors affecting treatment outcome of acute promyelocytic leukemia in Egyptian patients. J Clin Anal Med 2017;8(Suppl 5):480-484. doi:10.4328/JCAM.5456

Publication History

Received:
28.10.2017
Accepted:
13.12.2017
Published Online:
01.10.2017
Printed:
01.10.2017